Furthermore, approximately 80% of infant ALL cases carry leukemia-specific chromosomal translocations of the Mixed Lineage Leukemia (MLL, or KMT2A) gene, and this patient group in particular fares significantly worse with EFS rates of 30–40% [1,2]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.